NeuroAssets, a leading trans-Atlantic neuroscience consultancy, works with Pharma, Biotech and Foundations on strategic, operational, scientific, clinical, regulatory, business development and financing aspects. Clients include private and public biotech companies in Europe, USA and Japan.